Treatment for Patients With Osteoarthritis (OA) of the Knee
Phase 2
Completed
- Conditions
- Osteoarthritis
- Interventions
- Drug: placeboDrug: Intra-articular metHuIL-1ra (anakinra)
- First Posted Date
- 2005-05-17
- Last Posted Date
- 2008-02-22
- Lead Sponsor
- Amgen
- Target Recruit Count
- 165
- Registration Number
- NCT00110916
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Phase 3
Completed
- Conditions
- Low Bone Mineral DensityOsteopeniaBreast Cancer
- Interventions
- Drug: AMG 162 / DenosumabDrug: Placebo
- First Posted Date
- 2004-08-11
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Amgen
- Target Recruit Count
- 252
- Registration Number
- NCT00089661
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
Phase 2
Completed
- Conditions
- LymphomaBreast NeoplasmsLung NeoplasmsMultiple MyelomaChronic Lymphocytic Leukemia
- First Posted Date
- 2002-05-08
- Last Posted Date
- 2009-05-11
- Lead Sponsor
- Amgen
- Registration Number
- NCT00036023
© Copyright 2025. All Rights Reserved by MedPath